TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.

Yen-Shen Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.